Teva Pharmaceuticals USA, Inc

4 recalls

Date	Source	Product	Brand	Severity	Units
2026-03-11	FDA Drug	FDA Recall: Metoprolol Succinate Extended-Release Tablets, 50 mg, 100 tablets bottles (NDC: 45963-676-11) and 1,	Teva Pharmaceuticals USA, Inc	Class II	N/A
2026-03-11	FDA Drug	FDA Recall: Metoprolol Succinate Extended-Release Tablets, 25 mg, 100 tablets bottles (NDC: 45963-709-11) and 1,	Teva Pharmaceuticals USA, Inc	Class II	N/A
2026-03-11	FDA Drug	FDA Recall: Metoprolol Succinate Extended-Release Tablets, 200 mg, 100 tablets bottles, Rx Only, Teva Pharmaceut	Teva Pharmaceuticals USA, Inc	Class II	N/A
2026-03-11	FDA Drug	FDA Recall: Metoprolol Succinate Extended-Release Tablets, Rx Only, 100 mg, 100 tablets bottles (NDC: 45963-677-	Teva Pharmaceuticals USA, Inc	Class II	N/A